![Cancers | Free Full-Text | The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy Cancers | Free Full-Text | The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy](https://www.mdpi.com/cancers/cancers-10-00242/article_deploy/html/images/cancers-10-00242-g001-550.jpg)
Cancers | Free Full-Text | The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
![Antigen identification and high-throughput interaction mapping by reprogramming viral entry | bioRxiv Antigen identification and high-throughput interaction mapping by reprogramming viral entry | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/09/20/2021.09.18.460796/F2.large.jpg)
Antigen identification and high-throughput interaction mapping by reprogramming viral entry | bioRxiv
![Antigen identification and high-throughput interaction mapping by reprogramming viral entry | Nature Methods Antigen identification and high-throughput interaction mapping by reprogramming viral entry | Nature Methods](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41592-022-01436-z/MediaObjects/41592_2022_1436_Fig2_HTML.png)
Antigen identification and high-throughput interaction mapping by reprogramming viral entry | Nature Methods
![NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease - ScienceDirect NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120331323-gr1.jpg)
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease - ScienceDirect
![PDF) Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4(*)0101-0103 and recognized by CD4+ T lymphocytes of patients with NY-ESO-1-expressing melanoma PDF) Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4(*)0101-0103 and recognized by CD4+ T lymphocytes of patients with NY-ESO-1-expressing melanoma](https://www.researchgate.net/profile/Michael-Arand/publication/12630359/figure/fig7/AS:667121201733636@1536065497235/ELISPOT-assay-with-autologous-APCs-pulsed-with-NYESO-1-derived-peptide-22-and-the_Q320.jpg)
PDF) Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4(*)0101-0103 and recognized by CD4+ T lymphocytes of patients with NY-ESO-1-expressing melanoma
Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma
![Computationally profiling peptide:MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies | bioRxiv Computationally profiling peptide:MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2022/10/18/2022.07.15.500208/F2.large.jpg)
Computationally profiling peptide:MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies | bioRxiv
![SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade. - Abstract - Europe PMC SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4938367/bin/koni-05-06-1169353-g006.jpg)